Dexcom Inc [NASDAQ: DXCM] stock went on an upward path that rose over 1.18% on Tuesday, amounting to a one-week price increase of more than 5.20%.
Over the last 12 months, DXCM stock dropped by -16.57%. The one-year Dexcom Inc stock forecast points to a potential upside of 27.47. The average equity rating for DXCM stock is currently 1.59, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $27.82 billion, with 400.73 million shares outstanding and 395.07 million shares in the current float. Compared to the average trading volume of 5.58M shares, DXCM stock reached a trading volume of 3738869 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Dexcom Inc [DXCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $95.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.59. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 26, 2024. While these analysts kept the previous recommendation, JP Morgan raised their target price from $145 to $75. The new note on the price target was released on July 26, 2024, representing the official price target for Dexcom Inc stock. Previously, the target price had yet another raise to $130, while Redburn Atlantic analysts kept a Neutral rating on DXCM stock.
The Average True Range (ATR) for Dexcom Inc is set at 2.18, with the Price to Sales ratio for DXCM stock in the period of the last 12 months amounting to 7.07. The Price to Book ratio for the last quarter was 11.43, with the Price to Cash per share for the same quarter was set at 7.79. Price to Free Cash Flow for DXCM in the course of the last twelve months was 41.81 with Quick ratio for the last quarter at 2.48.
DXCM Stock Performance Analysis:
Dexcom Inc [DXCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.20. With this latest performance, DXCM shares dropped by -0.40% in over the last four-week period, additionally sinking by -50.57% over the last 6 months – not to mention a drop of -16.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DXCM stock in for the last two-week period is set at 49.15, with the RSI for the last a single of trading hit 55.83, and the three-weeks RSI is set at 44.57 for Dexcom Inc [DXCM]. The present Moving Average for the last 50 days of trading for this stock 70.22, while it was recorded at 67.79 for the last single week of trading, and 110.17 for the last 200 days.
Insight into Dexcom Inc Fundamentals:
Dexcom Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.48 and a Current Ratio set at 2.82.
DXCM Stock EPS
With the latest financial reports released by the company, Dexcom Inc posted 0.5/share EPS, while the average EPS was predicted by analysts to be reported at 0.34/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.16. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 23.00%.
Dexcom Inc [DXCM] Institutonal Ownership Details
There are presently around $98.38%, or 98.68%% of DXCM stock, in the hands of institutional investors. The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 46.51 million shares, which is approximately 11.9203%. BLACKROCK INC., holding 34.52 million shares of the stock with an approximate value of $$3.91 billion in DXCM stocks shares; and BLACKROCK INC., currently with $$1.85 billion in DXCM stock with ownership which is approximately 4.1796%.
